Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis. Lizak N, Lugaresi A, Alroughani R, Lechner-Scott J, Slee M, Havrdova E, Horakova D, Trojano M, Izquierdo G, Duquette P, et al. J Neurol Neurosurg Psychiatry. 2016 Sep 28. PMID: 27683916. Abstract CommentRecommendBookmarkWatch